Related Experiment Videos
Factors that influence the efficacy of topical gentamicin prophylaxis for experimental Pseudomonas keratitis
Abstract:
We evaluated the efficacy of topical gentamicin prophylaxis for experimental Pseudomonas keratitis in rabbits by applying gentamicin in concentrations of 0.3 and 4 mg/100 ml, in both solution and ointment vehicles, one or four hours after a superficial stromal scratch was infected topically with Pseudomonas organisms. Under these conditions the most effective prophylaxis was that given early, in solution, and in high concentration.
Insights
Topical gentamicin prophylaxis is most effective for Pseudomonas keratitis in rabbits when administered early, using a high concentration solution. This study highlights optimal conditions for preventing this eye infection.
Area of Science:
- Ophthalmology
- Microbiology
- Pharmacology
Background:
- Pseudomonas keratitis is a severe eye infection.
- Prompt treatment is crucial for preventing vision loss.
- Topical antibiotics are a common treatment approach.
Purpose of the Study:
- To evaluate the efficacy of topical gentamicin for experimental Pseudomonas keratitis in rabbits.
- To determine the optimal concentration, vehicle, and timing for gentamicin prophylaxis.
Main Methods:
- Rabbits with superficial stromal scratches were infected with Pseudomonas.
- Topical gentamicin was applied at 0.3 and 4 mg/100 ml concentrations.
- Application occurred 1 and 4 hours post-infection, using solution and ointment vehicles.
Main Results:
- Early administration (1 hour post-infection) showed superior efficacy.
- High concentration (4 mg/100 ml) was more effective than low concentration (0.3 mg/100 ml).
- Solution vehicle demonstrated better prophylactic effects than ointment.
Conclusions:
- Early, high-concentration topical gentamicin in solution is the most effective prophylaxis for experimental Pseudomonas keratitis in rabbits.
- Timing and formulation significantly impact treatment success.
- Findings provide evidence-based recommendations for managing Pseudomonas keratitis.